ABBV
Price
$202.59
Change
-$2.60 (-1.27%)
Updated
Apr 3, 02:27 PM (EDT)
Capitalization
322.43B
22 days until earnings call
AMGN
Price
$307.66
Change
+$1.96 (+0.64%)
Updated
Apr 3, 02:28 PM (EDT)
Capitalization
151.69B
20 days until earnings call
Ad is loading...

ABBV vs AMGN

Header iconABBV vs AMGN Comparison
Open Charts ABBV vs AMGNBanner chart's image
ABBVIE
Price$202.59
Change-$2.60 (-1.27%)
Volume$1.29K
Capitalization322.43B
Amgen
Price$307.66
Change+$1.96 (+0.64%)
Volume$4.21K
Capitalization151.69B
ABBV vs AMGN Comparison Chart
Loading...
ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AMGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABBV vs. AMGN commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABBV is a Buy and AMGN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (ABBV: $205.19 vs. AMGN: $305.70)
Brand notoriety: ABBV and AMGN are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ABBV: 124% vs. AMGN: 62%
Market capitalization -- ABBV: $322.43B vs. AMGN: $151.69B
ABBV [@Pharmaceuticals: Major] is valued at $322.43B. AMGN’s [@Pharmaceuticals: Major] market capitalization is $151.69B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABBV’s FA Score shows that 3 FA rating(s) are green whileAMGN’s FA Score has 4 green FA rating(s).

  • ABBV’s FA Score: 3 green, 2 red.
  • AMGN’s FA Score: 4 green, 1 red.
According to our system of comparison, AMGN is a better buy in the long-term than ABBV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABBV’s TA Score shows that 4 TA indicator(s) are bullish while AMGN’s TA Score has 3 bullish TA indicator(s).

  • ABBV’s TA Score: 4 bullish, 4 bearish.
  • AMGN’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ABBV is a better buy in the short-term than AMGN.

Price Growth

ABBV (@Pharmaceuticals: Major) experienced а +1.93% price change this week, while AMGN (@Pharmaceuticals: Major) price change was -0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.50%. For the same industry, the average monthly price growth was -2.97%, and the average quarterly price growth was -7.90%.

Reported Earning Dates

ABBV is expected to report earnings on Apr 25, 2025.

AMGN is expected to report earnings on Apr 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.50% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABBV($322B) has a higher market cap than AMGN($152B). ABBV has higher P/E ratio than AMGN: ABBV (66.46) vs AMGN (22.66). AMGN YTD gains are higher at: 18.847 vs. ABBV (16.559). ABBV has higher annual earnings (EBITDA): 17.2B vs. AMGN (14.8B). ABBV has more cash in the bank: 12.8B vs. AMGN (10.9B). ABBV has less debt than AMGN: ABBV (59.4B) vs AMGN (64.6B). ABBV has higher revenues than AMGN: ABBV (54.3B) vs AMGN (28.2B).
ABBVAMGNABBV / AMGN
Capitalization322B152B212%
EBITDA17.2B14.8B116%
Gain YTD16.55918.84788%
P/E Ratio66.4622.66293%
Revenue54.3B28.2B193%
Total Cash12.8B10.9B117%
Total Debt59.4B64.6B92%
FUNDAMENTALS RATINGS
ABBV vs AMGN: Fundamental Ratings
ABBV
AMGN
OUTLOOK RATING
1..100
5584
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
23
Undervalued
PROFIT vs RISK RATING
1..100
518
SMR RATING
1..100
1716
PRICE GROWTH RATING
1..100
4546
P/E GROWTH RATING
1..100
219
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMGN's Valuation (23) in the Biotechnology industry is somewhat better than the same rating for ABBV (77) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew somewhat faster than ABBV’s over the last 12 months.

ABBV's Profit vs Risk Rating (5) in the Pharmaceuticals Major industry is in the same range as AMGN (18) in the Biotechnology industry. This means that ABBV’s stock grew similarly to AMGN’s over the last 12 months.

AMGN's SMR Rating (16) in the Biotechnology industry is in the same range as ABBV (17) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew similarly to ABBV’s over the last 12 months.

ABBV's Price Growth Rating (45) in the Pharmaceuticals Major industry is in the same range as AMGN (46) in the Biotechnology industry. This means that ABBV’s stock grew similarly to AMGN’s over the last 12 months.

AMGN's P/E Growth Rating (9) in the Biotechnology industry is in the same range as ABBV (21) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew similarly to ABBV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABBVAMGN
RSI
ODDS (%)
Bearish Trend 2 days ago
35%
Bearish Trend 2 days ago
56%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
45%
Bullish Trend 2 days ago
60%
Momentum
ODDS (%)
Bearish Trend 2 days ago
38%
Bearish Trend 2 days ago
51%
MACD
ODDS (%)
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
44%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
47%
Advances
ODDS (%)
Bullish Trend 4 days ago
59%
Bullish Trend 4 days ago
57%
Declines
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 2 days ago
51%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
51%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
48%
View a ticker or compare two or three
Ad is loading...
ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AMGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FWRG18.420.51
+2.85%
First Watch Restaurant Group
FUL58.040.86
+1.50%
HB Fuller Company
GPN99.601.16
+1.18%
Global Payments
UTMD55.78-0.22
-0.39%
Utah Medical Products
BTOG0.18-0.02
-10.11%
Bit Origin Limited

ABBV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABBV has been loosely correlated with PFE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ABBV jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABBV
1D Price
Change %
ABBV100%
-0.52%
PFE - ABBV
54%
Loosely correlated
+0.65%
JNJ - ABBV
40%
Loosely correlated
+1.38%
AMGN - ABBV
35%
Loosely correlated
-0.40%
NVS - ABBV
33%
Poorly correlated
+1.06%
BMY - ABBV
32%
Poorly correlated
+0.08%
More

AMGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with PFE. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGN
1D Price
Change %
AMGN100%
-0.40%
PFE - AMGN
43%
Loosely correlated
+0.65%
GSK - AMGN
38%
Loosely correlated
-0.61%
NVS - AMGN
35%
Loosely correlated
+1.06%
ABBV - AMGN
35%
Loosely correlated
-0.52%
BIIB - AMGN
33%
Loosely correlated
-0.54%
More